InvestorsObserver
×
News Home

Should Drug Manufacturers - Specialty & Generic Stock Canopy Growth Corp (CGC) Be in Your Portfolio Tuesday?

Tuesday, September 21, 2021 01:32 PM | InvestorsObserver Analysts

Mentioned in this article

Should Drug Manufacturers - Specialty & Generic Stock Canopy Growth Corp (CGC) Be in Your Portfolio Tuesday?

Canopy Growth Corp (CGC) is around the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. CGC received an overall rating of 40, which means that it scores higher than 40 percent of all stocks. Canopy Growth Corp also achieved a score of 81 in the Drug Manufacturers - Specialty & Generic industry, putting it above 81 percent of Drug Manufacturers - Specialty & Generic stocks. Drug Manufacturers - Specialty & Generic is ranked 141 out of the 148 industries.

Overall Score - 40
CGC has an Overall Score of 40. Find out what this means to you and get the rest of the rankings on CGC!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 40 means the stock is more attractive than 40 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes

InvestorsObserver

’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Canopy Growth Corp Stock Today?

Canopy Growth Corp (CGC) stock has fallen -0.37% while the S&P 500 is up 0.25% as of 1:29 PM on Tuesday, Sep 21. CGC has fallen -$0.05 from the previous closing price of $13.52 on volume of 2,882,125 shares. Over the past year the S&P 500 is higher by 33.15% while CGC has fallen -14.42%. CGC lost -$1.79 per share the over the last 12 months. Click Here to get the full Stock Report for Canopy Growth Corp stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App